Spinal Muscular Atrophy Awareness Month

August is SMA (Spinal Muscular Atrophy) Awareness Month. SMA is a rare CNS condition causing a gradual loss of physical strength of all the muscles. It impacts the patient’s ability to eat, walk and and breathe.

GCT specializes in and has conducted numerous clinical studies in neurodegenerative and CNS diseases, including rare and genetic disorders. Let’s raise the public’s awareness about the Spinal Muscular Atrophy – together we can make a positive impact on the lives of those affected by SMA .

Subscribe to our mailing list

Marketing Permissions

Please select all the ways you would like to hear from Global Clinical Trials (GCT):

You can unsubscribe at any time by clicking the link in the footer of our emails. Please see our Privacy Policy. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

About

GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login

 

GCT

© 2001—2020 Global Clinical Trials, LLC

All rights reserved.